摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(4'-fluoro-[1,1'-biphenyl]-2-yl)-2-methylpropan-1-one | 1233011-96-5

中文名称
——
中文别名
——
英文名称
1-(4'-fluoro-[1,1'-biphenyl]-2-yl)-2-methylpropan-1-one
英文别名
1-[2-(4-Fluorophenyl)phenyl]-2-methylpropan-1-one
1-(4'-fluoro-[1,1'-biphenyl]-2-yl)-2-methylpropan-1-one化学式
CAS
1233011-96-5
化学式
C16H15FO
mdl
——
分子量
242.293
InChiKey
XCZUTBSWXGTLOL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.4
  • 重原子数:
    18
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.19
  • 拓扑面积:
    17.1
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    1-(4'-fluoro-[1,1'-biphenyl]-2-yl)-2-methylpropan-1-one 在 palladium diacetate 、 三氟乙酸silver(l) oxide 作用下, 反应 15.0h, 以92%的产率得到10,10-dimethyl-2-fluorophenanthrene-9(10H)-one
    参考文献:
    名称:
    Synthesis of Phenanthrone Derivatives from sec-Alkyl Aryl Ketones and Aryl Halides via a Palladium-Catalyzed Dual C−H Bond Activation and Enolate Cyclization
    摘要:
    A palladium-catalyzed chelation-assisted C-H activation of alkyl aryl ketones and their reaction with aryl iodides to afford ortho-arylated products is described. For sec-alkyl aryl ketones, the catalytic reaction proceeds further to give 10,10-dialkylphenanthrone derivatives. A possible reaction mechanism involving directed dual C-H bond activation and enolate cyclization for the formation of 10,10-dialkylphenanthrone derivatives is proposed.
    DOI:
    10.1021/ja1026248
点击查看最新优质反应信息

文献信息

  • Novel Ethanediamone Hepcidine Antagonists
    申请人:Dürrenberger Franz
    公开号:US20120214798A1
    公开(公告)日:2012-08-23
    The present invention relates to novel hepcidin antagonists of formula (I), pharmaceutical compositions comprising them and the use thereof as medicaments, in particular for treatment of disorders in iron metabolism, such as, in particular, iron deficiency diseases and anaemias, in particular anaemias in connection with chronic inflammatory diseases (ACD: anaemia of chronic disease and AI: anaemia of inflammation).
    本发明涉及一种新型的肝铁蛋白拮抗剂,其化学式为(I),包括它们的药物组合物以及将其用作药物的用途,特别是用于治疗代谢紊乱,如特别是缺乏病和贫血等疾病,特别是与慢性炎症性疾病相关的贫血(ACD:慢性疾病性贫血和AI:炎症性贫血)。
  • [EN] COMPOSITIONS AND METHODS FOR TREATING ESTROGEN-RELATED MEDICAL DISORDERS<br/>[FR] COMPOSITIONS ET PROCÉDÉS PERMETTANT DE TRAITER DES AFFECTIONS MÉDICALES ASSOCIÉES AUX ŒSTROGÈNES
    申请人:UNIV ILLINOIS
    公开号:WO2014066695A1
    公开(公告)日:2014-05-01
    Disclosed is a compound of formula (I). or a pharmaceutically acceptable salt thereof. Also disclosed are pharmaceutical compositions including the compound of formula (I) and methods of using the compound of formula (I).
查看更多